Nonalcoholic fatty liver disease (NAFLD ... and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis.

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...

where cancer from another part of the body spreads to the liver. Hepatocellular Carcinoma (HCC) stands out as the predominant form of primary liver cancer, particularly prevalent among individuals ...

Explore how the liver functions, common liver conditions, and tips to maintain liver health through lifestyle changes like ...

With the increasing prevalence of non-alcoholic fatty liver disease (NAFLD ... especially in lowering the risk of developing hepatocellular carcinoma (HCC) has recently attracted considerable ...

Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the heterogeneity of hepatocellular carcinoma (HCC) has not been ...

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...